Work

Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.17

Authors: Kurt Miller, Howard I. Scher, Karim Fizazi, Ethan M. Basch, Cora N. Sternberg, Mohammad Hirmand, David Cella, Cristina Ivanescu, De Phung, James Robert Spalding, Cat N. Bui, Stefan Holmstrom, Johann Sebastian De Bono

Institutions: Charité – Universitätsmedizin Berlin, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, Université Paris-Sud, Azienda Ospedaliera San Camillo-Forlanini, Medivation, Inc. (United States), Northwestern University, Astellas Pharma (Netherlands), Astellas Pharma (United States), Institute of Cancer Research

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591049264

Cites:

Cited by: 12

Related to: 10